Global Health
Alpha-adrenergic blockers – how do they work?
Alpha-adrenergic blockers or alpha-adrenergic antagonists affect the alpha receptors of the sympathetic nervous system. There are two kinds of alpha-adrenergic receptors: alpha-1 and alpha-2. Alpha-1 adrenergic receptors are present in vascular smooth muscle akin to the skin, gastrointestinal sphincters, kidneys, and brain, and cause vasoconstriction when activated by catecholamines (Nachawati and Patel, 2021). Alpha-2 adrenergic receptors are positioned in peripheral nerve endings and, when activated, inhibit the discharge of norepinephrine. Nonselective alpha-adrenergic antagonists cause vasodilation by blocking each alpha-1 and alpha-2 receptors.
By occupying the sites of alpha receptors, alpha-adrenergic blocking drugs cause the partitions of blood vessels to calm down. This results in dilation of blood vessels and a discount in peripheral vascular resistance (the pressure that the blood flowing through the vessel must overcome). This effect may end in orthostatic hypotension, i.e. a drop in blood pressure that happens when changing the position from lying right down to standing. Redistribution of blood into the dilated blood vessels of the legs causes hypotension.
.png.aspx?width=320&height=190;%20padding:10px;)
- Phenoxybenzamine (dibenzyline): Treats sweating and hypertension (HTN) related to pheochromocytoma.
- Phentolamine: Treats hypertensive episodes in patients with pheochromocytoma during preoperative preparation and surgical excision.
it causes blood vessels to dilate, which causes a drop in blood pressure, which is why it’s used to treat hypertension. Alpha-1 blockers also calm down prostate smooth muscle and are used to treat benign prostatic hyperplasia (BPH).
| (Facts and comparisons, 2022) | ||||||
| Alfuzosin | Doxazosin | Prazosin | Silodosin | Tamsulosin | Terazosin | |
| Not applicable | ||||||
| Lower urinary tract | Systemic | Postsynaptic | Lower urinary tract | Prostate | Systemic | |
| BPH | BPH HTN |
HTN | BPH | BPH | BPH HTN |
|
are currently under investigation and haven’t received approval from the Federal Medicines Agency (FDA).
Facts and Comparisons (2022). Alpha-1 adrenergic blockers. . Retrieved January 11, 2022 from https://online.factsandcomparisons.com/lco/action/doc/retrieve/docid/fc_dfc/5546106?cesid=4Z6bkQiTceV&
Nachawati, D. and Patel, J. (2021, July 6). Alpha blockers. . Downloaded from https://www.ncbi.nlm.nih.gov/books/NBK556066/
-
Well-Being2 years ago5 books that may help at work at work
-
Global Health2 months agoGlobal Fund Approves Emergency Financing for Malaria Prevention to Secure Ebola Response in Democratic Republic of the Congo – Press Releases
-
Best Practice2 months agoFrom the nightingale’s oath to the nurse’s oath
-
Global Health2 years agoThe Global Fund opens up the potential of private sector investment – updates
-
Education2 months agoTeachers and doctors lose the power to self-regulate. What is the chance?
-
Well-Being2 years agoFast and healthy advice on preparing meals for busy nurses
-
Well-Being2 years agoMaintenance of the nursing engine – each day nurse
-
Best Practice2 months agoA nurse’s lesson on grace
